USPTO serial 79272226
RAPIDLINK
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 8, 2020
- Examiner
- ARRIOLA, KIMBERLY
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with RAPIDLINK?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*
Plus Government fees of $325
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Megan E. Fink
Megan E. Fink Bodman PLC201 South Division Street, Suite 400Ann Arbor, MI 48104United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Surgical and medical apparatus and instruments, namely, surgical apparatus and instruments for medical use; artificial vascular grafts, artificial stent grafts, artificial thoracic, thoracoabdominal and abdominal stent grafts, surgical hybrid stent graft for treatment of thoracoabdominal aortic aneurysms, stents, and prostheses; surgical implants comprised of artificial materials; suture materials; implantable medical systems comprised of artificial stent grafts; implantable medical devices, namely, implantable prosthetic tubes for the surgical joining or substitution of the aortic arch blood vessels in cases of arterial dissection and aneurysm disease; artificial vascular grafts; artificial branched vascular grafts; artificial endovascular grafts; surgical graft materials namely, artificial endovascular grafts; medical devices namely, implantable prosthetic tubes for the surgical joining or substitution of the aortic arch blood vessels; surgical systems namely stent delivery systems; surgical systems for facilitating the revascularisation of the brain; surgical devices; devices comprising an artificial vascular graft and a stent; devices comprising an artificial vascular graft, a stent and a delivery system; medical systems and medical devices in the nature of surgical implants comprising artificial material and associated surgical instrument sets for use in thoracoabdominal procedures; medical systems and medical devices in the nature of surgical implants comprising artificial material and associated surgical instrument sets for use in aortic arch procedures; medical systems and medical devices in the nature of surgical implants comprising artificial material and associated surgical instrument sets for use in endovascular procedures; thoracic stents; artificial thoracic stent grafts; thoracoabdominal stents; artificial thoracoabdominal stent grafts; artificial stent graft systems; artificial stent graft devices; artificial stent graft systems and surgical devices comprising more than one component; artificial stent graft systems and surgical devices comprising components of more than one stent graft; artificial stent graft systems and surgical devices comprising components of more than one type of stent graft; devices comprising an artificial graft and stent joined together and compacted into a delivery system; artificial thoracic stent graft systems; artificial thoracic stent graft devices; artificial thoracoabdominal stent graft systems; artificial thoracoabdominal stent graft devices; delivery systems for artificial stents and grafts; delivery systems for artificial stent graft systems and artificial stent graft devices; medical systems, namely, minimally invasive devices for aneurysm repair; medical devices, namely, minimally invasive devices for aneurysm repair; medical systems, namely, minimally invasive devices for thoracoabdominal aortic aneurysm ('TAAA') repair; medical devices, namely, minimally invasive devices for thoracoabdominal aortic aneurysm ('TAAA') repair; cardiac valves for surgical prostheses; cardiac valve replacement systems namely, artificial cardiac valves; artificial heart valves; artificial heart valve conduits; artificial cardiac patches; artificial vascular patches; parts and fittings for surgical apparatus and instruments for medical use; parts and fittings for implantable devices for the surgical joining or substitution of the aortic arch blood vessels; parts and fittings for apparatus and instruments for facilitating the revascularisation of the brain | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 29, 2026 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Mar 20, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 20, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 20, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 20, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 20, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Dec 8, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Apr 4, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 11, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 11, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 8, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 8, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 22, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 22, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 2, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 19, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 17, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 16, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 16, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 1, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 16, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 16, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 18, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 17, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 16, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 26, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 22, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 21, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |